After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Kiniksa Pharmaceuticals International Plc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Kiniksa Pharmaceuticals International Plc is $3.14B. A total of 0.49 million shares were traded on the day, compared to an average of 434.82K shares.
In the most recent transaction, Quart Barry D sold 20,129 shares of KNSA for 41.51 per share on Dec 15 ’25. After the transaction, the Director now owns 12,546 company shares. In a previous transaction on Dec 15 ’25, Tessari Eben sold 12,048 shares at 41.56 per share. KNSA shares that CHIEF OPERATING OFFICER owns now total 16,666.
Among the insiders who bought shares, Quart Barry D acquired of 58,889 shares on Dec 15 ’25 at a per-share price of $41.51. In another insider transaction, Ragosa Mark sold 42,841 shares at $41.49 per share on Dec 08 ’25. Company shares held by the CHIEF FINANCIAL OFFICER now total 31,086.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, KNSA has a high of $42.98 and a low of $17.82.
As of this writing, KNSA has an earnings estimate of $0.42 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of $0.55 per share and a lower estimate of $0.29. The company reported an EPS of -$0.12 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. KNSA’s latest balance sheet shows that the firm has $182.20M in Cash & Short Term Investments as of fiscal 2021. There were $6.05M in debt and $44.82M in liabilities at the time. Its Book Value Per Share was $7.10, while its Total Shareholder’s Equity was $185.04M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KNSA is Buy with a score of 4.75.
